Evidence map›Paper›PMID 40176291›Full record

ArticleBritish journal of haematology2025

Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study.

C Giordano, M Picardi, N Pugliese, A Vincenzi, S Avilia, L De Fazio, M Lamagna, R Reina, A Scarpa, A Lombardi and 13 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

C GiordanoDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.ORCID https://orcid.org/0000-0003-3943-4263
M PicardiDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
N PuglieseDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
A VincenziDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.ORCID https://orcid.org/0009-0003-5975-9388
S AviliaDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
L De FazioDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
M LamagnaDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
R ReinaDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
A ScarpaDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
A LombardiDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
E VigliarDepartment of Public Health, Federico II University Medical School Naples, Naples, Italy.
G TronconeDepartment of Public Health, Federico II University Medical School Naples, Naples, Italy.
M MascoloDepartment of Advanced Biomedical Sciences, Federico II University Medical School, Naples, Italy.
C MainolfiDepartment of Translational Medical Sciences, Federico II University Medical School, Naples, Italy.
R FontiDepartment of Translational Medical Sciences, Federico II University Medical School, Naples, Italy.
S Del VecchioDepartment of Translational Medical Sciences, Federico II University Medical School, Naples, Italy.
V DamianoDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
R BiancoDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
F TrastulliHematology, Hospital "Antonio Cardarelli", Naples, Italy.
M AnnunziataHematology, Hospital "Antonio Cardarelli", Naples, Italy.
A SalemmeDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
M CarchiaDepartment of Translational Medical Sciences, Federico II University Medical School, Naples, Italy.
F PaneDepartment of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autologous haematopoietic stem cell transplantationbendamustine superchargebrentuximab vedotinrefractory Hodgkin lymphoma

Identifiers

PMID40176291
PMCPMC12078852

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.